Opus Genetics: The Future Lies In The Success Of The AAV Delivery Platform

Opus Genetics (IRD) rated Hold: valuation hinges on AAV gene therapy success. Track LCA5 Phase 3, 2026 data catalysts & ...

AI tool simplifies and scales complete genome assembly, supporting advances in diagnostics and precision medicine

An international research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) has developed HERRO, an ...

What a hair loss breakthrough could mean for women like me

As scientists edge closer to new treatments for hair loss, Victoria Derbyshire examines what such breakthroughs could mean ...

The Worst Health Habits You're Probably Picking Up In Middle Age

The budgeting of time to take care of your physical and mental health actually becomes even more important at this stage of ...

8 Intimidating Dog Breeds That Aren’t Right for Everyone

Some dogs look intimidating the moment they enter a room. A massive frame, deep bark, powerful jaws, muscular build, or ...

'Prostate cancer screening too late for my brother'

A man whose twin died with prostate cancer has said the news that tens of thousands more black men will be invited to ...
NAI500

Gene Editing Could Become the Next “Golden Rush” in the Pharmaceutical Industry, What Does This Mean for CRISPR Therapeutics?

The weight-loss drug market is currently one of the fastest-growing therapeutic areas in the pharmaceutical industry, and Eli ...
The Straits Times

‘It’s still working’: More are living with cancer as era of targeted drugs takes hold

CHICAGO – Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more than 20 years with the help of targeted drugs, drugs that harness the body’s immune system, ...